Acadia Pharmaceuticals (ACAD) reports Q4 results in line with EPS loss estimates but beats on...

|By:, SA News Editor

Acadia Pharmaceuticals (ACAD) reports Q4 results in line with EPS loss estimates but beats on revenue, largely due to the conclusion of its collaboration with Biovail in October 2010.